EXPERT PERSPECTIVES IN ATOPIC DERMATITIS

Experts in the field discuss new therapies and how they will impact the dermatologist's practice.

Diego Ruiz Dasilva, MD, FAAD: Achievement of Optimal Treatment Targets with Oral JAK Inhibition in Elderly Patients with Atopic Dermatitis

Dr. Dasilva discusses positive results from a recent study published in the Journal of Clinical and Aesthetic Dermatology that assessed the safety and efficacy of JAK inhibitors in a group of elderly patients. Click here to read the full article.

Reference:

  1. Dasilva DR, Desir N, Encarnacion IN, et al. Achievement of Optimal Treatment Targets with Oral Janus Kinase Inhibition in Elderly Patients with Atopic Dermatitis: A Real-world, Multicenter, Retrospective Study. J Clin Aesthet Dermatol. 2025;18(2):25–29.

MORE EXPERT PERSPECTIVES IN ATOPIC DERMATITIS